171 related articles for article (PubMed ID: 19500417)
1. Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication.
Azorin JM; Aubrun E; Bertsch J; Reed C; Gerard S; Lukasiewicz M
BMC Psychiatry; 2009 Jun; 9():33. PubMed ID: 19500417
[TBL] [Abstract][Full Text] [Related]
2. [Management of patients with acute manic or mixed episodes and outcome at three months].
Azorin JM; Luquiens A; Aubrun E; Reed C; Gasquet I; Lukasiewicz M
Encephale; 2010 Jun; 36(3):226-35. PubMed ID: 20620265
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
5. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
6. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
Bellantuono C; Barraco A; Rossi A; Goetz I
BMC Psychiatry; 2007 Jul; 7():33. PubMed ID: 17640381
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
9. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
[TBL] [Abstract][Full Text] [Related]
10. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study.
Hong J; Reed C; Novick D; Haro JM; Aguado J
Psychiatry Res; 2011 Nov; 190(1):110-4. PubMed ID: 21571375
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
Gonzalez-Pinto A; Vieta E; Reed C; Novick D; Barraco A; Aguado J; Haro JM
J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
[TBL] [Abstract][Full Text] [Related]
13. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study.
Haro JM; van Os J; Vieta E; Reed C; Lorenzo M; Goetz I;
Acta Psychiatr Scand; 2006 Feb; 113(2):112-20. PubMed ID: 16423162
[TBL] [Abstract][Full Text] [Related]
14. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
Reed C; Novick D; Gonzalez-Pinto A; Bertsch J; Haro JM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):715-21. PubMed ID: 19345251
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
[TBL] [Abstract][Full Text] [Related]
16. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.
Ogawa Y; Tajika A; Takeshima N; Hayasaka Y; Furukawa TA
CNS Drugs; 2014 Nov; 28(11):989-1003. PubMed ID: 25160685
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up.
Geller B; Tillman R; Bolhofner K; Zimerman B
Bipolar Disord; 2010 Mar; 12(2):164-71. PubMed ID: 20402709
[TBL] [Abstract][Full Text] [Related]
18. Treating mixed mania/hypomania: a review and synthesis of the evidence.
Takeshima M
CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
